Correlogic and Japanese Mass Spec Maker to Improve Clinical Mass Spectrometry | GenomeWeb
NEW YORK (GenomeWeb News) — Correlogic Systems has signed a research and development agreement with a Japanese mass-spec maker to enhance clinical mass spectrometry, Correlogic said today.
Correlogic and Tokyo-based JEOL, which also makes nuclear magnetic resonance instruments and electron optical equipment, have been involved in an “informal” research collaboration for more than a year, Correlogic said. The firm said they have “made great strides in the continuing validation of various mass spectrometer-based assays.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.